Phase 2/3, Multistage, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab Administered to Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Project: Research

Project Details

StatusActive
Effective start/end date5/12/24 → 4/12/26

Keywords

  • Clinical Trials
  • 80202135CDP3001

Clinical Trial Phase

  • Phase II